The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study)

Juan Zhao(Peking University), Zhuoli Zhang(Peking University), Wei Zhou(Peking University), Li Yang(Peking University), Xiaoyan Yan(Peking University), Yangfeng Wu(Peking University), Ping Ji(Peking University)
BMC Medical Informatics and Decision Making
March 4, 2021
Cited by 5


Related Papers